Senate Republicans examining health reform's effect on Medicare advantage

NewsGuard 100/100 Score
The Hill: "A quartet of Senate Republicans is calling on Medicare's top accountant to release the numbers behind his analysis of health reform's impact on the Medicare Advantage (MA) program. The lawmakers ... say the steep cuts to MA under the new reform law will cause many plans to fold, while many others will be forced to drop benefits to remain profitable. In April, Richard Foster, chief actuary at the Centers for Medicare and Medicaid Services (CMS), issued a report that largely supported those claims.  … The letter [to Foster] arrived just a few days after the Obama administration announced that enrollment in MA plans is projected to jump 5 percent next year, while average premiums will fall by 1 percent. Those figures, CMS officials said, belie the charges that the new law will cut benefits and hike costs" (Lillis, 9/27).

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Biden is right about $35 insulin cap but exaggerates prior costs for Medicare enrollees